Related Experiment Video
Updated: May 16, 2026

Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
Regulation of ROCK activity in cancer
Marie Morgan-Fisher1, Ulla M Wewer, Atsuko Yoneda
1Department of Biomedical Sciences, The Faculty of Health and Medical Sciences, and Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Denmark.
Abstract:
Cancer-associated changes in cellular behavior, such as modified cell-cell contact, increased migratory potential, and generation of cellular force, all require alteration of the cytoskeleton. Two homologous mammalian serine/threonine kinases, Rho-associated protein kinases (ROCK I and II), are key regulators of the actin cytoskeleton acting downstream of the small GTPase Rho. ROCK is associated with cancer progression, and ROCK protein expression is elevated in several types of cancer. ROCKs exist in a closed, inactive conformation under quiescent conditions, which is changed to an open, active conformation by the direct binding of guanosine triphosphate (GTP)-loaded Rho. In recent years, a number of ROCK isoform-specific binding partners have been found to modulate the kinase activity through direct interactions with the catalytic domain or via altered cellular localization of the kinases. Thus, these findings demonstrate additional modes to regulate ROCK activity. This review describes the molecular mechanisms of ROCK activity regulation in cancer, with emphasis on ROCK isoform-specific regulation and interaction partners, and discusses the potential of ROCKs as therapeutic targets in cancer.
Insights
Rho-associated protein kinases (ROCKs) regulate the actin cytoskeleton and are crucial in cancer progression. This review details ROCK regulation and their potential as cancer therapeutic targets.
Area of Science:
- Cell Biology
- Molecular Oncology
- Biochemistry
Background:
- Cancer progression involves altered cellular behaviors like migration and cell-cell contact, driven by cytoskeletal changes.
- Rho-associated protein kinases (ROCK I and II) are key regulators of the actin cytoskeleton, downstream of the Rho GTPase.
- Elevated ROCK protein expression is observed in various cancer types, implicating ROCK in cancer progression.
Purpose of the Study:
- To review the molecular mechanisms regulating ROCK activity in the context of cancer.
- To emphasize ROCK isoform-specific regulation and interaction partners.
- To discuss the therapeutic potential of ROCKs as cancer targets.
Main Methods:
- Literature review focusing on molecular mechanisms of ROCK regulation.
- Analysis of studies on ROCK isoform-specific binding partners and their impact on kinase activity.
- Examination of the role of ROCK in cancer progression and its potential as a therapeutic target.
Main Results:
- ROCKs are regulated by conformational changes induced by GTP-loaded Rho.
- ROCK activity is modulated by isoform-specific binding partners through direct interactions or altered localization.
- These interactions represent additional modes of ROCK activity regulation.
Conclusions:
- Understanding ROCK regulation is crucial for cancer research.
- ROCK isoform-specific regulation and interaction partners offer insights into cancer progression.
- ROCKs represent promising therapeutic targets for cancer treatment.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer
Regulation of Metabolism
